Atrium Therapeutics grants new hire stock options for 7,000 shares at USD 11.76 exercise price

Reuters2026/07/20 21:59

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Atrium Therapeutics granted equity awards on July 20, 2026 under its 2026 Employment Inducement Incentive Award Plan for one new non-executive hire.
Package totals 7,000 non-qualified stock options priced at USD 11.76 per share, based on the Nasdaq close on the grant date.
Options vest 25% after one year, then monthly over 36 months; 3,500 restricted stock units vest 25% after one year, then annually over three years.
The inducement plan was adopted by the board in April 2026; awards were granted outside stockholder-approved equity plans.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrium Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA08504) on July 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Atrium Therapeutics grants new hire stock options for 7,000 shares at USD 11.76 exercise price

You may also like

Crypto prices